|
|
| | 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-hydroxy- Basic information |
| Product Name: | 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-hydroxy- | | Synonyms: | 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-hydroxy-;WUN-29654;CRBN modulator-1;2-(2,6-Dioxopiperidin-3-yl)-5-hydroxy-1H-benzo[de]isoquinoline-1,3(2H)-dione;CRBN modulator1,CRBN modulator-1,inhibit,CRBN modulator 1,Ligands for E3 Ligase,E3 ligase-recruiting Moiety,Inhibitor;3-(2,6-dioxopiperidin-3-yl)-7-hydroxy-3-azatricyclo[7.3.1.0?,13]trideca-1(13),5,7,9,11-pentaene-2,4-dione;3-(2,6-dioxopiperidin-3-yl)-11-hydroxy-3-azatricyclo[7.3.1.0^{5,13}]trideca-1(13),5,7,9,11-pentaene-2,4-dione;CRBN modulator-1, 10 mM in DMSO | | CAS: | 2407829-65-4 | | MF: | C17H12N2O5 | | MW: | 324.29 | | EINECS: | | | Product Categories: | | | Mol File: | 2407829-65-4.mol | ![1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-hydroxy- Structure](CAS/20200611/GIF/2407829-65-4.gif) |
| | 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-hydroxy- Chemical Properties |
| Boiling point | 680.0±50.0 °C(Predicted) | | density | 1.587±0.06 g/cm3(Predicted) | | solubility | DMSO : 10 mg/mL (30.84 mM; ultrasonic and adjust pH to 2 with HCl) | | form | Solid | | pka | 8.27±0.20(Predicted) | | color | Light green to green |
| | 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-hydroxy- Usage And Synthesis |
| Uses | CRBN modulator-1, a Thalidomide analog and a CRBN modulator extracted from WO2020006262A1, compound 10, has an IC50 of 3.5 μM and a Ki of 0.98 μM[1]. | | Biological Activity | CRBN modulator-1, a Thalidomide analog and a CRBN modulator extracted from WO2020006262A1, compound 10, has an IC50 of 3.5 μM and a Ki of 0.98 μM[1]. | | IC 50 | Cereblon | | References | [1]. Nathanael Gray, et al. New crbn modulators. WO2020006262A1. |
| | 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-hydroxy- Preparation Products And Raw materials |
|